GH Research
GHRS · NASDAQ
$19.17+$0.885 (+4.84%)TodayMarket closed ·
Prev close $18.28
Who owns GHRS
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 93.6% of GHRS’s shares.
- Schonharting (Florian)21.6%
- Lynx1 Capital Advisors LLC19.3%
- BVF Partners L.P.12.6%
- RA Capital Management, LP11.1%
- Next 6 largest institutions28.8%
- All other shareholders6.4%
| Holder | Shares | % of shares |
|---|---|---|
| Schonharting (Florian) | 14.82M | 21.62% |
| Lynx1 Capital Advisors LLC | 13.26M | 19.35% |
| BVF Partners L.P. | 8.65M | 12.62% |
| RA Capital Management, LP | 7.64M | 11.14% |
| Fidelity Management & Research Company LLC | 5.98M | 8.72% |
| RTW Investments L.P. | 5.93M | 8.65% |
| Deep Track Capital LP | 3.33M | 4.86% |
| Avoro Capital Advisors LLC | 1.80M | 2.63% |
| Terwey (Theis) | 1.78M | 2.60% |
| Foresite Capital Management, LLC | 940.49K | 1.37% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Growth Company Fund | 1.90M | 2.77% |
| Fidelity Growth Company K6 Fund | 616.54K | 0.90% |
| Fidelity Series Growth Company Fund | 476.70K | 0.70% |
| iShares Biotechnology ETF | 362.54K | 0.53% |
| Fidelity Select Biotechnology Portfolio | 173.40K | 0.25% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of GHRS in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Schonharting Florian | Award | 2.30K | — |
| Moore Duncan | Award | 2.20K | — |
| Hanley Dermot John | Award | 2.20K | — |
| Forer Michael | Award | 100.00K | — |
| Forer Michael | Award | 2.20K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 1.76M
- Days to cover
- 5.00
- % of shares outstanding
- 2.57%
- Average daily volume
- 352.81K
- Change since last report
- −34.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.